key: cord-0686890-4jur8uxr authors: Pérez-Lago, Laura; Sola Campoy, Pedro J; Buenestado-Serrano, Sergio; Pharmacy, Pilar Catalán; Estévez, Agustín; de la Cueva Technician, Víctor Manuel; López, Mariana G; Tecnichian, Marta Herranz; Suárez-González, Julia; Alcalá, Luis; Comas, Iñaki; González-Candelas, Fernando; Muñoz, Patricia; García de Viedma, Darío title: Epidemiological, clinical and genomic snapshot of the first 100 B.1.1.7 SARS-CoV-2 cases in Madrid date: 2021-03-24 journal: J Travel Med DOI: 10.1093/jtm/taab044 sha: 15a60737f385e7d494d7e45fd0d4aa0b15b308d5 doc_id: 686890 cord_uid: 4jur8uxr We present clinical, genomic and epidemiological data on the first 106 cases with the SARS-CoV-2 B.1.1.7 variant in Madrid. Even from the start, the increase of this variant was due to transmission events within the community, some causing extensive clusters, rather than further imports. Most cases developed non-severe disease. A new SARS-CoV-2 variant, B.1.1.7, emerged in September in the UK, and is responsible for 76.6% of COVID-19 cases. 1 This variant has also been reported in another 45 countries, 17 of them European. 2 ,3 B.1.1.7 is considered to have higher transmissibility. 4 It carries an unusually high number of specific mutations/deletions, 18, mostly non-synonymous and eight concentrate in the S gene, 5 including several which might have relevant functional roles. The 69/70 deletion may be associated to immune response evasion 6 and the N501Y substitution increases the affinity to the ACE2 receptor. 7 These findings have raised the alarm of having to face a new variant with the potential to accelerate the spread of the pandemic. A recent report finds a realistic possibility that B.1.1.7 is associated with an increased risk of death. 8 More data on the behaviour of the B.1.1.7 variant once imported are needed to further understand its potential risks at a wider context. The aim of this study was to analyse the first 106 incident COVID-19 cases in Madrid (650 000 inhabitants covered by our tertiary hospital) infected by the B.1.1.7 variant. We based our initial screening on the S gene signal dropout in the TaqPath assay (ThermoFisher, Waltham, USA) caused by the 69/70 deletion. 9 This screening criterion, based on the S signal dropout, has been accepted as a suitable proxy to identify the B.1.1.7 variant, with 100% specificity over the past weeks in the UK. 1 Our first B. (Figure 1a) shows the diversity among the sequences, consistent with the circulating time of this lineage in the UK, 10 before being imported to Spain. Moreover, the integration of our WGS data with those from the B.1.1.7 sequences available from the UK in GISAID shows that the cases in Madrid correspond to sequences distributed throughout the tree (Figure 1b) . To estimate the most recent common ancestor (MRCA) a multi-sequence alignment was performed, including the 88 B.1.1.7 sequences from Madrid and 67 additional sequences belonging to global SARS-CoV-2 diversity (Supplementary Methods). Before phylogenetic dating, root-totip regression of genetic divergence against sampling dates was performed to investigate the molecular clock signal using Tem-pEst v 1. Focusing on Madrid sequences, 55 cases (61%) are involved in 14 clusters (0 SNPs between the cases sharing cluster, size 2-14; Figure 1a) , suggesting post-importation transmission chains. Four out of the six cases who had arrived from the UK and 10 of the 11 individuals who had links with people recently arrived from that country were involved in some of these clusters (Figure 1a, Supplementary Table 1 ). One large cluster (cluster 1), involving 14 cases, was identified, while the remaining clusters were smaller (2-5 cases; Figure 1a ). Cluster 1 involved members of four different households (2, 2, 3 and 3 individuals); two of these family units were acquaintances and another two clustered cases knew one individual of one these families (Figure 1a, Supplementary Table 1 ). The next two largest clusters were number 9 and 16, which included five and six cases. Cluster 9 involved one household (five members) and a 2-year-old case without relationships with those in the cluster. Similarly, cluster 16 included five members from the same household and one unrelated case (Figure 1a) . These data exemplify community transmissions in which the same strain is transmitted in different close circles and extends beyond them. Links were also found between the cases included in eight of the smaller clusters (all household-related except two involving close contact between partners or friends, Figure 1a , Supplementary Table 1) . We present valuable clinical and epidemiological data on the first 106 cases diagnosed with the new SARS-CoV-2 B.1.1.7 variant in Madrid that will help understand its dynamics once introduced into a new population. In our context, 16.3% of all newly diagnosed cases carry the B.1.1.7 variant 1 month after its first detection and most developed non-severe disease. The great majority of the cases infected with B.1.1.7, including the first identified case, had no direct or indirect links to the UK. Thus, even from the start, the increase of this variant in our context is mostly due to post-importation transmission events within the community rather than further imports. One of the transmission clusters identified by genomic viral analysis was very large and alerts on the need of more efficient control measures to minimize a rapid transmission of the B.1.1.7 variant. Supplementary data are available at JTM online. Kestler (Martha), López (Juan Carlos), Losada (Carmen Narcisa), Machado (Marina) Investigation of novel SARS-CoV-2 variant: variant of concern 202012/01. Tecnical briefing 4 SARS-CoV-2 lineages Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2 Investigation of novel SARS-CoV-2 variant: variant of concern 202012/01 Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70 The high infectivity of SARS-CoV-2 B.1.1.7 is associated with increased interaction force between spike-ACE2 caused by the viral N501Y mutation NERVTAG note on B.1.1.7 severity Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom Investigation of novel SARS-CoV-2 variant: variant of concern 202012/01 The authors are particularly indebted to Rocío Fernández del Rey and Iván Adán Rodríguez for their efficiency and productivity, instrumental to obtain the clinical and epidemiological data. We are grateful to Dainora Jaloveckas (cienciatraducida.com) for editing and proofreading assistance. The authors declare no conflict of interest. This work was supported by Instituto de Salud Carlos III (Ref COV20/00140: SeqCOVID-Consorcio para la epidemiología genómica de SARS-CoV-2 en España) and by Consejo Superior de Investigaciones Científicas (CSIC) (PTI Salud Global). LPL holds a Miguel Servet Contract CP15/00075).